Xu Y - Search Results

1

Optimal preservation condition for the extraction of cell-free DNA from bile of patients with biliary tract cancer.

Yang J, Zhao T, Nian B, Yang C, Zhu Y, Xu Y, Xu X, Chen S, Li Z, Zhang W, Zhang D, Lu K, Zhang F. Yang J, et al. Among authors: xu x, xu y. Transl Cancer Res. 2024 Oct 31;13(10):5328-5338. doi: 10.21037/tcr-24-843. Epub 2024 Oct 29. Transl Cancer Res. 2024. PMID: 39525024 Free PMC article.

2

Rpb3 promotes hepatocellular carcinoma through its N-terminus.

Fang ZP, Jiang BG, Zhang FB, Wang AD, Ji YM, Xu YF, Li JC, Zhou WP, Zhou WJ, Han HX. Fang ZP, et al. Oncotarget. 2014 Oct 15;5(19):9256-68. doi: 10.18632/oncotarget.2389. Oncotarget. 2014. PMID: 25211001 Free PMC article.

3

Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma.

Xu Y, Han H, Zhang F, Lv S, Li Z, Fang Z. Xu Y, et al. Oncol Lett. 2015 Jan;9(1):300-304. doi: 10.3892/ol.2014.2686. Epub 2014 Nov 7. Oncol Lett. 2015. PMID: 25435979 Free PMC article.

4

Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial-mesenchymal transition.

Xu Y, Wang B, Zhang F, Wang A, Du X, Hu P, Zhu Y, Fang Z. Xu Y, et al. Onco Targets Ther. 2017 Feb 24;10:1191-1198. doi: 10.2147/OTT.S127100. eCollection 2017. Onco Targets Ther. 2017. PMID: 28280353 Free PMC article.

5

A clinical study of choledochoscopic holmium laser lithotripsy for multiple intrahepatic calculi within ERAS programs.

Wang C, Lv S, Wang A, Zhang F, Wang B, Xu Y, Zhu Y, Fang Z. Wang C, et al. Among authors: xu y. Lasers Surg Med. 2019 Feb;51(2):161-166. doi: 10.1002/lsm.23004. Epub 2018 Jul 19. Lasers Surg Med. 2019. PMID: 30024034

6

The role of vesicular overexpressed in cancer pro-survival protein 1 in hepatocellular carcinoma proliferation.

Fang Z, Wu L, Dai H, Hu P, Wang B, Han Q, Xu Y, Lv S, Zhu Y, Gan M, Zhou W, Zhang W. Fang Z, et al. Among authors: xu y. Cancer Biomark. 2020;28(1):9-20. doi: 10.3233/CBM-190574. Cancer Biomark. 2020. PMID: 32083568

7

RNA polymerase II subunit 3 regulates vesicular, overexpressed in cancer, prosurvival protein 1 expression to promote hepatocellular carcinoma.

Hu P, Wang B, Chen T, Xu Y, Zheng G, Zhu Y, Du X. Hu P, et al. Among authors: xu y. J Int Med Res. 2021 Apr;49(4):300060521990512. doi: 10.1177/0300060521990512. J Int Med Res. 2021. Retraction in: J Int Med Res. 2024 Jan;52(1):3000605241228165. doi: 10.1177/03000605241228165 PMID: 33845647 Free PMC article. Retracted.

8

Lesion human leukocyte antigen-E is associated with favourable prognosis for patients with oesophageal squamous cell carcinoma.

Xu YF, Du XF, Li ZY, Fang ZP, Zhang FB. Xu YF, et al. J Int Med Res. 2021 Oct;49(10):3000605211047278. doi: 10.1177/03000605211047278. J Int Med Res. 2021. PMID: 34617814 Free PMC article.

9

SNHG3 regulates NEIL3 via transcription factor E2F1 to mediate malignant proliferation of hepatocellular carcinoma.

Zhang F, Lu J, Yang J, Dai Q, Du X, Xu Y, Zhang C. Zhang F, et al. Among authors: xu y. Immunogenetics. 2023 Feb;75(1):39-51. doi: 10.1007/s00251-022-01277-2. Epub 2022 Sep 17. Immunogenetics. 2023. PMID: 36114381

10

Transcription Factor MAZ Potentiates the Upregulated NEIL3-mediated Aerobic Glycolysis, thereby Promoting Angiogenesis in Hepatocellular Carcinoma.

Zhang F, Wang B, Zhang W, Xu Y, Zhang C, Xue X. Zhang F, et al. Among authors: xu y. Curr Cancer Drug Targets. 2024;24(12):1235-1249. doi: 10.2174/0115680096265896231226062212. Curr Cancer Drug Targets. 2024. PMID: 38347781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,558 results

Search Page

Filters